HGH 191AA (Somatropin)

Somatropin 191AA: Research Overview and Laboratory Applications

Introduction and Scientific Context

Somatropin, a recombinant version of human pituitary-derived growth hormone, consists of 191 amino acids arranged identically to the naturally occurring endogenous hormone. Laboratory researchers assess somatropin within controlled experimental systems to investigate its effects on tissue growth processes, amino acid incorporation into proteins, and regulatory control of metabolic pathways through activation of growth hormone receptor signaling and downstream IGF-1 (insulin-like growth factor-1) signaling networks.

Somatropin research applications span investigations of skeletal and muscular tissue physiology, liver and adipose tissue biochemistry, cellular regeneration and repair biology, and endocrine regulatory systems. Scientists evaluate somatropin's influence on cell replication, metabolic nutrient handling, and receptor-mediated signaling pathways related to anabolic and metabolic effects in experimental cell culture and whole-organism research models.

Research Applications and Scientific Utility

Somatropin finds significant application across diverse research fields, including experimental growth hormone insufficiency models, metabolic regulation analysis, mitochondrial performance evaluation, and cellular regeneration research. In laboratory environments, researchers employ somatropin to investigate the biochemical and physiological foundations of tissue homeostasis, energy metabolism, and physiological restructuring in standard and stress-induced experimental conditions.

Typical research investigations utilize somatropin to evaluate its effects on muscle mass development, bone mineral content, lipid mobilization and metabolism, and nutrient distribution patterns. These studies illuminate how growth hormone signaling influences muscle-building metabolism, cellular energy generation, and metabolic stability. Somatropin also serves as an essential investigative tool for examining molecular pathways controlling tissue regeneration, protein synthesis and breakdown, and physiological cellular adaptation within defined laboratory models.

Structural Properties and Chemical Identity

Somatropin is a linear polypeptide hormone composed of 191 sequentially arranged amino acids. Mass spectrometric batch analysis confirms structural and compositional identity.

Molecular weight measured by mass spectrometry: 22,124 Da Purity determined by HPLC: 99.42% Batch identification: 2025007 Retention time: 3.48 min Analysis instrument: LCMS-7800 Series (Calibrated) Analytical note: Major peak confirmed with minor secondary peak at 0.58% relative area

Research Investigation Categories

Metabolic Regulation and Energy Studies

Somatropin is employed in controlled laboratory metabolic models to examine its effects on lipid breakdown, carbohydrate metabolism, and energy homeostasis. Studies focus on how somatropin regulates nutrient utilization, substrate oxidation, and metabolic rate through growth hormone and IGF-1 receptor signaling pathways. This research enhances knowledge of hormone-regulated energy balance and macronutrient metabolism.

Growth, Tissue Repair, and Regeneration Studies

Research using somatropin investigates its role in bone formation, collagen protein synthesis, and regenerative cell processes associated with tissue healing and development. Studies highlight somatropin's contributions to musculoskeletal system restructuring, connective tissue homeostasis, and wound repair through anabolic and growth-promoting signaling.

Endocrine Feedback and Regulation Studies

Laboratory experiments employ somatropin to examine endocrine feedback regulation and interactions with intrinsic hormone regulatory systems. Research explores somatropin's effects on hypothalamic-pituitary communication, feedback inhibition, and hormonal adjustment within integrated endocrine networks.

Restriction Statement

This substance is designated exclusively for controlled research applications conducted by qualified research personnel. It is not approved for human clinical use or animal medical application.

Author Credentials and Attribution

This literature compilation was organized, reviewed, and edited by Dr. Shlomo Melmed, M.D., an internationally recognized endocrinologist and academic institution leader specializing in pituitary hormone regulation, growth hormone physiology, and endocrine disease mechanisms. Dr. Melmed's research has significantly advanced understanding of growth hormone regulation, receptor signaling, and the pathophysiology of growth hormone deficiency and excess. His work has substantially shaped modern scientific knowledge of endocrine control mechanisms, metabolic regulation, and growth hormone therapeutic applications.

Collaborative Research and Contributor Acknowledgment

Dr. Shlomo Melmed has authored and co-authored numerous peer-reviewed publications on growth hormone biology, receptor signaling, and endocrine system regulation. His collaborative research with distinguished researchers Dr. Jens O.L. Jørgensen, Dr. Fariba Dehkhoda, Dr. Par Arner, Dr. Catherine D. Moyes, and Dr. Arumugam Vijayakumar has established foundational understanding of somatropin's metabolic actions, regenerative functions, and hormonal feedback mechanisms.

These collaborative research contributions have significantly influenced current scientific understanding of growth hormone physiology and receptor signaling pathways.

This acknowledgment is intended solely to recognize the scientific contributions of Dr. Melmed and collaborating researchers. It should not be interpreted as endorsement or promotion of this compound. Dr. Melmed and his affiliated institutions maintain no commercial, professional, or research relationships with somatropin manufacturers or distributors.

Scientific References

Brinkman JE, et al. Physiology, Growth Hormone. StatPearls. 2023. https://pubmed.ncbi.nlm.nih.gov/29489209/ Dehkhoda F, et al. The growth hormone receptor: mechanism of receptor activation. Front Endocrinol. 2018. https://pubmed.ncbi.nlm. nih.gov/29695930/ Jørgensen JOL, et al. Growth hormone and metabolism. J Endocrinol. 2018. https://pubmed.ncbi.nlm.nih.gov/30002165/ Vijayakumar A, et al. IGF-1 in skeletal growth and repair. Bone Res. 2020. https://pubmed.ncbi.nlm.nih.gov/33224327/ Moyes CD, et al. Mitochondrial responses to hormonal regulation. Am J Physiol Endocrinol Metab. 2021. https://pubmed.ncbi.nlm.g ov/34187182/ Melmed S. Pathophysiology of adult growth hormone deficiency. Endocr Rev. 2019. https://pubmed.ncbi.nlm.nih.gov/30809687/ ClinicalTrials.gov. Study of recombinant human growth hormone in metabolic regulation. https://clinicaltrials.gov/ct2/show/NCT031030 Arner P, et al. Hormonal lipolysis mechanisms in adipose tissue. Nat Rev Endocrinol. 2015. https://pubmed.ncbi.nlm.nih.gov/25421179/